Accent MicrocellNSE:ACCENTMIC +0.33%19 ROA % is 15.26% as of Mar. 2025, which is 28% above its 10-year median of 11.92. GuruFocus rates NSE:ACCENTMIC with a GF Score™ of 19/100. The stock has 6 warning signs investors should review. Among 1,005 Drug Manufacturers companies, Accent Microcell ranks better than 92.44% on this metric.
ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. Accent Microcell's annualizedNet Income for the quarter that ended in Mar. 2025 was ₹331 Mil.
Accent Microcell's average Total Assets over the quarter that ended in Mar. 2025 was ₹2,166 Mil. Therefore, Accent Microcell's annualized ROA % for the quarter that ended in Mar. 2025 was 15.26%.
The historical rank and industry rank for Accent Microcell's ROA % or its related term are showing as below:
NSE:ACCENTMIC'
s ROA % Range Over the Past 10 Years
Min: 5.95 Med: 11.92 Max: 19.12
Current: 15.26
During the past 5 years, Accent Microcell's highest ROA % was 19.12%. The lowest was 5.95%. And the median was 11.92%.
NSE:ACCENTMIC's ROA % is ranked better than 92.44% of 1005
companies
in the Drug Manufacturers industry
Industry Median: 2.72
vs NSE:ACCENTMIC: 15.26
ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A banks ROA % is typically well under 2%.
Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:
Note:
The Net Income data used here is one times the annual (Mar. 2025) net income data. The Revenue data used here is one times the annual (Mar. 2025) revenue data.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).
Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.
E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.
Accent Microcell ROA % Related Terms
Accent Microcell ROA % Historical Data
* Premium members only.
The historical data trend for Accent Microcell's ROA % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Accent Microcell ROA % Chart
Accent Microcell Annual Data
Trend
Mar21
Mar22
Mar23
Mar24
Mar25
ROA %
5.95
6.72
11.92
19.12
15.26
Accent Microcell Semi-Annual Data
Mar21
Mar22
Mar23
Mar24
Mar25
ROA %
5.95
6.72
11.92
19.12
15.26
NSE:ACCENTMIC vs ZTS, UTHR: ROA % Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Accent Microcell's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Accent Microcell ROA % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Accent Microcell's ROA % distribution charts can be found below:
* The bar in red indicates where Accent Microcell's ROA % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data,
the Net Income data used here is one times the annual (Mar. 2025) net income data.
ROA % is displayed in the 30-year financial page.
Accent Microcell (NSE:ACCENTMIC) has a ROA % of 15.26% as of Mar. 2025. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Accent Microcell and its competitors. This is 28% above median its historical median of 11.92. Over the past decade, Accent Microcell's ROA % has ranged from 5.95 to 19.12. According to the industry distribution chart, Accent Microcell ranks #76 out of 1005 companies in the Drug Manufacturers industry, placing it in the top 7.6%.
Is Accent Microcell's ROA % too high?
Accent Microcell's current ROA % of 15.26% is 28% above median its 10-year median of 11.92. Over the past 10 years, this metric has ranged from a low of 5.95 to a high of 19.12. The Drug Manufacturers industry median ROA % is 2.72. Accent Microcell's value of 15.26% is 461% above this industry median. Based on the distribution chart, Accent Microcell ranks #76 out of 1005 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Accent Microcell has a GF Score™ of 19/100, reflecting its overall financial health beyond just this single metric.
How does Accent Microcell's ROA % compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Accent Microcell ranks #76 out of 1005 companies for ROA %. This places Accent Microcell in the top 8% of its industry — outperforming the majority of peers. The industry median ROA % is 2.72. Accent Microcell's value of 15.26% is 461% above this benchmark. Historically, Accent Microcell's own ROA % has ranged from 5.95 to 19.12 over the past decade. While the company's 10-year median is 11.92 vs. the industry median of 2.72, Accent Microcell has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROA % for a Drug Manufacturers company?
The median ROA % among Drug Manufacturers companies is 2.72, based on 1,005 companies in the industry. Companies in the top quartile (top 25%) have a ROA % significantly above this median, while those in the bottom quartile fall well below. However, ROA % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Accent Microcell's current ROA % of 15.26% is 461% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROA % mean?
A high ROA % can signal that a stock is expensive relative to its fundamentals. Return on assets is the ratio of current-period net income to average two-period total assets. View historical data on Accent Microcell and its competitors. For the Drug Manufacturers industry, the median ROA % is 2.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Accent Microcell's current ROA % is 15.26%, which is 28% above median its own 10-year median of 11.92. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Accent Microcell stock overvalued right now?
Accent Microcell (NSE:ACCENTMIC) has a current ROA % of 15.26%. The current ROA % is 15.26%, which is 28% above median its 10-year median of 11.92 and 461% above the Drug Manufacturers industry median of 2.72. Accent Microcell's overall GF Score™ is 19/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROA % calculated?
ROA % is calculated from a company's financial statements. For Accent Microcell (NSE:ACCENTMIC), the current ROA % is 15.26% as of Mar. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Accent Microcell Ltd is engaged in the manufacturing business of pharmaceutical excipients including products like Microcrystalline Cellulose which is a term for refined wood pulp and is used as a texturizer, an anti-caking agent, a fat substitute, an emulsifier, an extender, and a bulking agent in food production; Croscarmellose Sodium used as a super disintegrant in pharmaceutical formulations; Magnesium Stearate; Cellulose Powder, and others. Its business segments are segregated based on the location of its manufacturing facilities and include Dahej (SEZ Unit), Pirana, Unit III, and Inter Unit Sales. Geographically, a majority of the company's revenue is derived through the export of its products to various countries.
19GF Score
Get the complete analysis for NSE:ACCENTMIC
ROA % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ACCENTMIC has been successfully added to your 